A mixed-methods study investigating the potential and challenges of generic substitution of controlled substances in community pharmacies
I.M. Keller, J.M. Alexa, M.W. Meier, S.S. Allemann

TL;DR
This study explores the lower substitution rate of generic controlled substances in pharmacies and the challenges pharmacists face, suggesting better collaboration and education to improve patient care.
Contribution
The study provides new insights into the specific challenges and support needs for substituting generic controlled substances in community pharmacies.
Findings
Controlled substances had a significantly lower substitution rate (37%) compared to non-controlled substances (74%).
Pharmacists cited high administrative workload and legal regulations as major challenges.
Physicians prescribed originals and generics at similar rates for both controlled and non-controlled substances.
Abstract
Using generics became an established practice. Studies about dispensing practices of generic controlled substances are scarce. We investigated dispensing practices of generic controlled substances compared to non-controlled substances, challenges community pharmacists face when substituting them, and how they can be better supported. A mixed-methods approach was employed. We descriptively analyzed prescribing and dispensing rates of originals and generics of controlled and non-controlled substances. Ten community pharmacists were interviewed to investigate challenges and support options. Seven hundred eight prescriptions were included in the data analysis. Physicians prescribed 54 % (167/307) of originals for controlled substances and 50 % (202/401) of originals for non-controlled substances (p > 0.05). A total of 37 % (62/167) of prescriptions for original controlled substances were…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPharmaceutical Economics and Policy · Pharmaceutical studies and practices · Medication Adherence and Compliance
